Roy A. Ehling

Also affiliated with Aimmune Therapeutics (United Kingdom)

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)”.

Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.19.473354

N/A

0DataRank · unranked

18 citations

Chang-Il Kim, Roy A. Ehling, Alec Pankow, Xaquín Castro Dopico, Darren P. Martin +6 more